Stocks & ETFs

Latest News

Blogs & Articles

Stratagy Backtesting

Portfolio Analyser

Price Analyser

Compare Stocks

Stock & ETF Screener

Pricing

About The Company

CEO

Ms. Karen Sue Lynch

Market Cap

84.54 Billion USD

Sector

Healthcare

Website

https://www.cvshealth.com

Last Update

2/22/2024, 12:00:00 PM

Description

CVS Health Corporation provides health services in the United States.

Read More

Overview

Value

82

Growth

51

Health

41

Management

31

Analyst Opinion

91

Total

59

All Scores Out Of 100

Best Features

  • Earnings growth has improved recently
  • Has a low level of debt
  • Price-to-earnings ratio of 11.4 is lower than the market average (19.6x)
  • Has a margin-of-safety above fair value
  • Liked by analysts
  • Has strong dividend growth

Risk Factors

  • There is a history of diluting shareholders
  • Does not hold enough liquid assets to cover short term liabilities
  • Disliked by Twitter users
  • Very undervalued

Market Peers

CVS

Key Figures

PE Ratio (TTM)

11.45

Margin Of Safety (DCF)

204.60%

Revenue Growth (5 Year Average)

9.55%

Ratings Consensus

Strong Buy

Share Buybacks

-5.16%

Dividend Yeild (TTM)

3.35%

Valuation

Value Score

82

  • Price-to-earnings ratio of 11.4 is lower than the market average (19.6x)
  • Free-cashflow-yeild of 11.12% is better than the market average (4.7%)
  • Margin-of-safety of 204.60% is better than the market average (17.95%)
  • Estimated intrinsic-value of 226.32 USD is higher than current price ( 67.17 USD)

Desired Margin Of Safety

0%

Tip: Set your desired Margin Of Safety

Free Cash Flow Type

Annual Cashflow Growth

0%

Discount Rate

0%

Buy Target: < 163.8 USD

Current Price: 74.3 USD

How Does This Work?

Show Advanced Options

This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.

Price/Earnings

11.45x

Free Cashflow Yeild

11.12%

PE/Earnings Growth

N/A

Price/Book

1.22x

Growth

Growth Score

51

  • Revenue growth has improved this yeara
  • Earnings growth has improved this year
  • 5 Year Average Cashflow growth of 16.65% is higher than the market average (12.35%)
  • 5 Year Average Revenue growth of 9.55% is lower than the market average (10.97%)
  • 5 Year Average Earnings growth of 8.27% is lower than the market average (14.48%)
  • Free Cashflow growth has slowed this year

Revenue Growth

9.55%

Earnings Growth

8.27%

Cashflow Growth

16.65%

Health

Health Score

41

  • Debt repayments do not significantly impact cashflow
  • Has a high level of debt
  • Assets do not cover liabilities
  • Requires debt for normal operation to be sustainable

Altman Z Score

2.22

Piostroski Score

6.00

Debt/Equity

1.00x

Current Assets/Liabilities

0.94x

Free Cashflow/Total Debt

0.19x

Debt/Capital

1.08x

Dividend

Secure Dividend Score

57

  • Dividend yeild of 3.35% is more than the market average (1.85%)
  • Dividend is likely safe
  • Long term dividend payout ratio of -22.18% is considered good
  • Payout ratio (TTM) of 37.54% is lower than the average (40%)
  • Dividends have shown growth over the last 5 years
  • Spending a higher percentage of their income on dividends than last 5 years

Dividend Yeild

3.35%

Dividend Growth

10.74%

Payout Ratio (Earnings)

37.54%

Payout Ratio (Cashflow)

30.13%

Management

Management Score

31

  • Has returned higher dividends when earnings have risen
  • Return-on-capital-employed of 2.65% is lower than the market average (10%)
  • Has issued new shares whilst share price is low
  • Has a history of diluting shareholders to finance activity
  • Return-on-equity of 5.60% is lower than the market average (15%)

Average Buybacks/Dilution

-5.16%

Recent Buybacks/Dilution

-4.08%

5 Year Price Volitility

20.30%

Return On Assets

1.74%

Return On Capital Employed

2.65%

Return On Equity

5.60%

Return On Free Cashflow

N/A

Return On Investments

16.66%

Social Sentiment

Social Sentiment Score

0

Twitter Sentiment

N/A

Stocktwits Sentiment

N/A

Analysts

Analyst Opinion

91

  • Ratings consensus is Strong Buy

SEC Filings

Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.

Other Information

Company Name

CVS Health Corporation

Currency

USD

Beta

0.604166

Vol Avg

8818042

Ceo

Ms. Karen Sue Lynch

Cik

0000064803

Cusip

126650100

Exchange

New York Stock Exchange

Full Time Employees

219000

Industry

Healthcare Plans

Sector

Healthcare

Ipo Date

1973-02-21

Address

One CVS Drive

City

Woonsocket

State

RI

Country

US

Zip

02895

Phone

401-765-1500

Analysis Last Updated

2/22/2024, 12:00:00 PM

All financial data provided by FMP

Noticed an error with something on our site?

We Use Cookies